Asston Pharmaceuticals IPO
Asston Pharmaceuticals IPO is priced at ₹115 to ₹123 per share ,
Each share has a face value of ₹10.
Asston Pharmaceuticals IPO is offering its shares to the public for the first time through an IPO on the stock exchanges BSE SME.
The total amount they aim to raise is 22,41,000 shares (aggregating up to ₹27.56 Cr).
Asston Pharmaceuticals IPO open date is 9 July, 2025 and the IPO will close on 11 July, 2025.
|
Check Live IPO GMP List 👈
|
|
Check Live IPO Subscription List 👈
|
|
Check All IPO Allotment List 👈
|
Live Day 1
|
Asston Pharmaceuticals IPO Details
| IPO Category Type: | SME IPO |
| IPO Open: | 9 July, 2025 |
| IPO Close: | 11 July, 2025 |
| IPO Price Band: | ₹115 to ₹123 per share |
| Face Value: | ₹10 Per Equity Share |
| IPO Listing exchange: | BSE SME |
| IPO Issue Type: | Book Build Issue |
| IPO Size: | Approx 22,41,000 shares (aggregating up to ₹27.56 Cr) |
| Fresh Issue: | Approx Approx 21,28,000 shares (aggregating up to ₹26.17 Cr) |
| Offer for Sale: | Approx [.] |
Asston Pharmaceuticals IPO GMP Today
Last Updated - 9 July, 2025 5:21 pm
Asston Pharmaceuticals IPO's GMP is ₹20 on 9 July, 2025 5:21 pm. If you add this to the IPO price, which is ₹123, you get an estimated listing price of ₹143. This means there's a potential gain of 16.3% per share.The GMP is updated daily.Keep an eye on daily updates to see how the IPO price is trending.
Asston Pharmaceuticals IPO's GMP is ₹20 on 9 July, 2025 5:21 pm. If you add this to the IPO price, which is ₹123, you get an estimated listing price of ₹143. This means there's a potential gain of 16.3% per share.The GMP is updated daily.Keep an eye on daily updates to see how the IPO price is trending.
| IPO Price : | 123 Rs |
| IPO GMP : | 20 Rs 👈 |
| Expected Listing Price : | 123+20 = 143 Rs |
| Expected IPO Gain %: | 16.3% 👈 |
| Rating : | ★★☆☆☆ |
| One Lot Shares: | 1000 |
| One Lot Price: | 1,23,000 Rs |
| One Lot Expected Listing: | 1,43,000 Rs |
| One Lot Expected Profit: | 20,000 Rs 👈 |
Asston Pharmaceuticals IPO Subscription Status
Last Updated - 9 July, 2025 5:21 pm
Asston Pharmaceuticals IPO's subscription started on 9 July, 2025 and will close on 11 July, 2025. The retail quota is 33.29%, QIB is 47.30% and NII is 14.37%.
Asston Pharmaceuticals IPO's subscription started on 9 July, 2025 and will close on 11 July, 2025. The retail quota is 33.29%, QIB is 47.30% and NII is 14.37%.
| QIB - Qualified Institutional Buyers: | 3.51x |
| NII - Non-Institutional Investors: | 0.66x |
| SNII - Small Non-Institutional Investors: - Bid below ₹10L | [.]x |
| BNII - Big Non-Institutional Investors: - Bid above ₹10L | [.]x |
| RII - Retail Individual Investor: | 1.22x |
| Total: | 1.75x 👈 |
Asston Pharmaceuticals IPO Allotment Status
Asston Pharmaceuticals IPO Allotment Status is to be decided on 14 July, 2025. The refund will be initiated on 15 July, 2025 and the shares will be credited to the Demat account on 15 July, 2025.
| IPO Registrar | Page Link |
|---|---|
| Maashitla Securities Private Limited | IPO Allotment Page |
| BSE | BSE IPO Allotment Page |
| NSE | NSE IPO Allotment Page |
| IPO Key | IPO Key Allotment Status Page |
Asston Pharmaceuticals IPO Allotment 14 July, 2025 after evening.
Asston Pharmaceuticals IPO Reservation
| Retail Quota: | 33.29% |
| QIB Quota: | 47.30% |
| NII Quota: | 14.37% |
| Employee Discount: | [.] |
Asston Pharmaceuticals IPO Prospectus
| DRHP Draft Prospectus: | Continue Reading |
| RHP Draft Prospectus: | Continue Reading |
| Anchor Investors List: | [.] |
Asston Pharmaceuticals IPO Market Lot Details
| Lot Size | Shares | Amount | |
|---|---|---|---|
| Retail Minimum | 1 | 1000 | ₹123000 |
| Retail Maximum | 1 | 1000 | ₹123000 |
| HNI Minimum | 2 | 2000 | ₹246000 |
Asston Pharmaceuticals IPO Dates
| IPO Activity | Date |
|---|---|
| Open Date: | 9 July, 2025 |
| Close Date: | 11 July, 2025 |
| Allotment Date: | 14 July, 2025 |
| Refund Date: | 15 July, 2025 |
| Shares Credit Date: | 15 July, 2025 |
| Listing Date: | 16 July, 2025 |
Asston Pharmaceuticals Company Financial Report
| Period Ended | 31 May 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 31.83 | 28.12 | 20.26 | 13.69 |
| Revenue | 6.21 | 25.61 | 15.84 | 7.19 |
| Profit After Tax | 1.32 | 4.33 | 1.36 | 1.06 |
| EBITDA | 1.93 | 6.16 | 2.55 | 1.52 |
| Net Worth | 12.04 | 10.72 | 6.39 | 1.99 |
| Reserves and Surplus | 5.77 | 4.45 | 5.61 | 1.29 |
| Total Borrowing | 7.83 | 7.26 | 6.82 | 5.25 |
| Amount in ₹ Crore | ||||
Asston Pharmaceuticals Company Address
| Company | Asston Pharmaceuticals Limited |
|---|---|
| Address | 4th Floor, Office No. A-431 Balaji Bhavan, Plot No 42A Sector-11 CBD Belapur, Navi Mumbai, Thane Navi Mumbai, Maharashtra, 400614 |
| Phone | +91 22 49731411 |
| info@asstonpharmaceuticals.com | |
| Website | http://www.asstonpharmaceuticals.com/ |
Asston Pharmaceuticals IPO Registrar
| Company | Maashitla Securities Private Limited |
|---|---|
| Phone | +91-11-45121795-96 |
| ipo@maashitla.com | |
| Website | https://maashitla.com/allotment-status/public-issues |
Asston Pharmaceuticals IPO Lead Manager
- Sobhagya Capital Options Ltd
Asston Pharmaceuticals IPO - FAQs
Q.What is Asston Pharmaceuticals IPO?
Ans.Asston Pharmaceuticals IPO is a SME IPO. The IPO is list on BSE SME.
Q.When Asston Pharmaceuticals IPO will open?
Ans.Asston Pharmaceuticals IPO is to open on 9 July, 2025 for Investors.
Q.What is Asston Pharmaceuticals IPO GMP Today?
Ans.Asston Pharmaceuticals IPO GMP Today is Check Here
Q.What is Asston Pharmaceuticals IPO Size?
Ans.Asston Pharmaceuticals IPO size is 22,41,000 shares (aggregating up to ₹27.56 Cr).
Q.What is Asston Pharmaceuticals IPO Price Band?
Ans.Asston Pharmaceuticals IPO Price Band is ₹115 to ₹123 per share.
Q.What is the Asston Pharmaceuticals IPO Allotment Date?
Ans.Asston Pharmaceuticals IPO allotment date is 14 July, 2025.
Q.How to check Asston Pharmaceuticals IPO Allotment Status?
Ans.To check Asston Pharmaceuticals IPO allotment status Check Here
Q.What is the Asston Pharmaceuticals IPO Listing Date?
Ans.Asston Pharmaceuticals IPO listing date is 16 July, 2025. The IPO is to list on BSE SME.